Premium
Administration of immunoglobulin G‐degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti‐ ADAMTS 13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission
Author(s) -
Stubbs Matthew J.,
Thomas Mari,
Vendramin Chiara,
Sonesson Elisabeth,
Kjellman Christian,
Järnum Sofia,
Stenberg Yvonne,
Elfving Charlotte,
Scully Marie
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15706
Subject(s) - adamts13 , rituximab , medicine , thrombotic thrombocytopenic purpura , immunology , thrombotic microangiopathy , antibody , von willebrand factor , autoantibody , plasmapheresis , gastroenterology , platelet , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom